Josh Hexter

Mr. Hexter serves as Chief Operating and Business Officer of Oramed Pharmaceuticals. Mr. Hexter has nearly two decades of prominent leadership, business development, and operations know-how, entrepreneurialism and management experience in the life science sector.

Prior to his current position, Mr. Hexter was Chief Business Officer of BrainsWay Ltd. (NASDAQ/TASE: BWAY). Previously, he served as the Chief Operating Officer of Oramed. Mr. Hexter has also served as Executive Director of Corporate In-Licensing at BioLineRx (NASDAQ/TASE: BLRX) and in the private equity and venture capital sector where he served as CEO of a VC-backed start-up. As founder and CEO of Biosensor Systems Design, Mr. Hexter was instrumental in shaping the company’s strategic focus and in forging strategic agreements with Fortune 100 companies in the areas of food safety, medical diagnostics, and homeland security.

Mr. Hexter earned a bachelor’s degree from the University of Wisconsin and a master’s degree in management from Boston University.